Invention Grant
- Patent Title: Targeting microRNAs for metabolic disorders
-
Application No.: US15272619Application Date: 2016-09-22
-
Publication No.: US09862950B2Publication Date: 2018-01-09
- Inventor: Balkrishen Bhat , Neil W. Gibson , Diedre MacKenna , Brandee Wagner , David P. Bartel
- Applicant: Regulus Therapeutics Inc.
- Applicant Address: US CA San Diego
- Assignee: Regulus Therapeutics Inc.
- Current Assignee: Regulus Therapeutics Inc.
- Current Assignee Address: US CA San Diego
- Agency: McNeill Baur PLLC
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; A61K31/7088 ; A61K45/06 ; A61K31/713 ; A61K47/48
Abstract:
Described herein are compounds comprising modified oligonucleotides that are complementary to miR-103 and/or miR-107 and methods of treating diseases and disorders using the compounds.
Public/Granted literature
- US20170067051A1 TARGETING MICRORNAS FOR METABOLIC DISORDERS Public/Granted day:2017-03-09
Information query
IPC分类:
